Anke Salmen

St. Josef-Hospital — Germany

Medicine · Health Sciences

29h-index3.1kcitations195works4.92yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Multiple Sclerosis Research Studies(132), Peripheral Neuropathies and Disorders(37), Polyomavirus and related diseases(22), Systemic Lupus Erythematosus Research(18), Immunotherapy and Immune Responses(16)

Publications191 total

Improving reliability and accuracy of structured data extraction using a consensus large-language model approach–a use case description in multiple sclerosis
Frontiers in Artificial Intelligence·2026· 1 citedOpen Access
Choroid plexus enlargement associates with serum neurofilament and predicts relapse-free progression in multiple sclerosis
Cell Reports Medicine·2026Open Access
1597eTiP NEOGAP-CRC-01: A first-in-human phase I/IIa trial of personalised tumour trained lymphocytes (pTTL) in stage IV colorectal cancer
Annals of Oncology·2025
A First-in-Human, phase I/IIa trial of the novel T cell immunotherapy pTTL in patients with advanced colorectal cancer
British journal of surgery·2025Open Access
HLA-A∗03:01 as predictive genetic biomarker for glatiramer acetate treatment response in multiple sclerosis: a retrospective cohort analysis
EBioMedicine·2025· 1 citedOpen Access
Case Report: Improvement of diplopia due to severe internuclear ophthalmoplegia by 4-aminopyridine documented using a novel virtual reality-based oculography headset
Frontiers in Virtual Reality·2025Open Access
Neurological and Immunological Insights Into Post-COVID-19 Syndrome: A Single-Center Retrospective Study.
PubMed·2025Open Access
Real-world use of disease-modifying therapy in persons with multiple sclerosis aged 55 and over
BMJ Neurology Open·2025Open Access
Personalized treatment decision algorithms for the clinical application of serum neurofilament light chain in multiple sclerosis: A modified Delphi Study
Multiple Sclerosis Journal·2025· 2 citedOpen Access
Treatment of Three Autoimmune Neuropathies with Autologous CD19-Targeted CAR-T Cells (S18.002)
Neurology·2025· 2 cited
Treatment persistence and clinical outcomes in patients starting B cell depleting therapies within the Swiss MS Cohort
Universität Zürich, ZORA·2025Open Access
Real-world use of disease-modifying therapy in persons with multiple sclerosis aged 55 and over
Universität Zürich, ZORA·2025Open Access
Cellular and humoral vaccination response under immunotherapies—German consensus on vaccination strategies in neurological autoimmune diseases
Therapeutic Advances in Neurological Disorders·2025Open Access
Treatment persistence and clinical outcomes in patients starting B cell depleting therapies within the Swiss MS Cohort
Multiple Sclerosis Journal - Experimental Translational and Clinical·2025· 1 citedOpen Access
Disability progression is a question of definition—A methodological reappraisal by example of primary progressive multiple sclerosis
Multiple Sclerosis and Related Disorders·2024· 2 citedOpen Access
Gadolinium contrast-enhanced lesion segmentation in multiple sclerosis: a deep-learning approach.
Proceedings on CD-ROM - International Society for Magnetic Resonance in Medicine. Scientific Meeting and Exhibition/Proceedings of the International Society for Magnetic Resonance in Medicine, Scientific Meeting and Exhibition·2024
Factors associated with low health-related quality of life in persons with multiple sclerosis: A quantile-based segmentation approach
PLoS ONE·2024· 3 citedOpen Access
437 Personalized tumor-trained lymphocytes – a neoantigen targeted T cell therapy product for treatment of colorectal cancer
Regular and Young Investigator Award Abstracts·2024· 1 citedOpen Access
Serum Glial Fibrillary Acidic Protein and Neurofilament Light Chain Levels Reflect Different Mechanisms of Disease Progression under B‐Cell Depleting Treatment in Multiple Sclerosis
Annals of Neurology·2024· 32 citedOpen Access
Comparative targeted lipidomics between serum and cerebrospinal fluid of multiple sclerosis patients shows sex and age-specific differences of endocannabinoids and glucocorticoids
Acta Neuropathologica Communications·2024· 12 citedOpen Access
page 1 of 10Next →

Frequent Co-authors

Andrew Chan(26), Ralf Gold(23), Robert Hoepner(17), Frauke Zipp(15), Heinz Wiendl(14), Antonios Bayas(14), Friedemann Paul(14), Uwe K. Zettl(14), Brigitte Wildemann(13), Bernhard Hemmer(13), Claudio Gobbi(12), Tania Kümpfel(12), Felix Luessi(12), Sven G. Meuth(12), Martin Stangel(12), Björn Tackenberg(12), Florian Then Bergh(12), Ralf A. Linker(11), Sergiu Groppa(11), Caroline Pot(10)